Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-8-10
pubmed:abstractText
Positron emission tomography (PET) is a non-invasive imaging modality used in the diagnosis and staging of breast cancer. However, several factors can affect fluoro-deoxyglucose (FDG) uptake by a tumor. To clarify the parameters that most affect FDG accumulation in tumors, the relationship between standardized uptake values (SUVs) and clinicopathological factors and immunohistopathological analysis was investigated in breast cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1340-6868
pubmed:author
pubmed:issnType
Print
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
260-8
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17690502-Adenocarcinoma, Scirrhous, pubmed-meshheading:17690502-Adult, pubmed-meshheading:17690502-Aged, pubmed-meshheading:17690502-Breast Neoplasms, pubmed-meshheading:17690502-Carcinoma, Ductal, Breast, pubmed-meshheading:17690502-Female, pubmed-meshheading:17690502-Fluorodeoxyglucose F18, pubmed-meshheading:17690502-Humans, pubmed-meshheading:17690502-Injections, Intravenous, pubmed-meshheading:17690502-Lymphatic Metastasis, pubmed-meshheading:17690502-Middle Aged, pubmed-meshheading:17690502-Neoplasm Staging, pubmed-meshheading:17690502-Neoplasms, Hormone-Dependent, pubmed-meshheading:17690502-Positron-Emission Tomography, pubmed-meshheading:17690502-Radiopharmaceuticals, pubmed-meshheading:17690502-Receptor, erbB-2, pubmed-meshheading:17690502-Receptors, Estrogen, pubmed-meshheading:17690502-Receptors, Progesterone
pubmed:year
2007
pubmed:articleTitle
The relationship between FDG uptake in PET scans and biological behavior in breast cancer.
pubmed:affiliation
Department of Surgical Oncology, Dokkyo Medical University, Shimotsuge, Tochigi, Japan.
pubmed:publicationType
Journal Article